Deal Making with AI and Big Data: New Frontiers in Drug Discovery and Development

Life sciences and healthcare companies are increasingly leveraging AI, machine learning and data assets in complex partnering deals that are redefining the way we think about discovery and development of therapeutics, and clinical decision-making. Join senior executives from Tempus Labs and leading biotechnology and biopharma companies to learn how they leverage AI platforms and valuable data assets to forge partnerships with big pharma and leading healthcare providers. Discussion topics will include, but are not limited to, dealmaking considerations as well as licensing, data and regulatory issues associated with the technology.